0001237899-12-000013.txt : 20120111 0001237899-12-000013.hdr.sgml : 20120111 20120111175539 ACCESSION NUMBER: 0001237899-12-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120110 FILED AS OF DATE: 20120111 DATE AS OF CHANGE: 20120111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Terifay Robert J CENTRAL INDEX KEY: 0001391382 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 12522841 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0304 4 2012-01-10 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001391382 Terifay Robert J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Commercial Common Stock 2012-01-10 4 M 0 18128 21.34 A 27500 D Common Stock 2012-01-10 4 F 0 5233 73.92 D 22267 D Common Stock 2012-01-10 4 F 0 4651 73.92 D 17616 D Common Stock 2012-01-10 4 M 0 1872 21.92 A 19488 D Common Stock 2012-01-10 4 F 0 554 73.92 D 18934 D Common Stock 2012-01-10 4 F 0 543 73.92 D 18391 D Common Stock 2012-01-11 4 S 0 9019 74.2 D 9372 D Common Stock 1387 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 21.34 2012-01-10 4 M 0 18128 D 2017-02-26 Common Stock 18128 0 D Non-Qualified Stock Option (right to buy) 21.92 2012-01-10 4 M 0 1872 D 2017-12-17 Common Stock 1872 35628 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 9,019 shares of Company stock on January 11, 2012 at prices ranging from $74.10 to $74.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 11, 2012 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Robert J. Terifay 2012-01-11